Clinical Trials Browser

Phase EARLY_PHASE1 × Nivolumab × CNS × Clear all

NCT07210632 2026-02-27

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Phase EARLY_PHASE1 Not yet recruiting

Brain Neoplasms, Glioma

NCT05704933 2025-10-20

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Phase EARLY_PHASE1 Completed

CNSDermatologic

Brain Neoplasms, Melanoma